Detalhe da pesquisa
1.
Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.
Cell
; 171(2): 481-494.e15, 2017 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28985567
2.
Oncogenic role of the SOX9-DHCR24-cholesterol biosynthesis axis in IGH-BCL2+ diffuse large B-cell lymphomas.
Blood
; 139(1): 73-86, 2022 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34624089
3.
The whole-genome landscape of Burkitt lymphoma subtypes.
Blood
; 134(19): 1598-1607, 2019 11 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31558468
4.
Identifying transcriptional profiles and evaluating prognostic biomarkers of HIV-associated diffuse large B-cell lymphoma from Malawi.
Mod Pathol
; 33(8): 1482-1491, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32080349
5.
Extracellular vesicles in DLBCL provide abundant clues to aberrant transcriptional programming and genomic alterations.
Blood
; 132(7): e13-e23, 2018 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29967128
6.
Dasatinib Is Preferentially Active in the Activated B-Cell Subtype of Diffuse Large B-Cell Lymphoma.
J Proteome Res
; 18(1): 522-534, 2019 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30540191
7.
Man's best friend: what can pet dogs teach us about non-Hodgkin's lymphoma?
Immunol Rev
; 263(1): 173-91, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25510277
8.
Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma.
Blood
; 128(26): 3083-3100, 2016 12 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27760757
9.
Barking up the right tree: advancing our understanding and treatment of lymphoma with a spontaneous canine model.
Curr Opin Hematol
; 24(4): 359-366, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28426554
10.
A phase II trial of bendamustine in combination with rituximab in older patients with previously untreated diffuse large B-cell lymphoma.
Br J Haematol
; 175(2): 281-289, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27448091
11.
The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells.
Blood
; 123(19): 2988-96, 2014 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-24682267
12.
Increased BCR responsiveness in B cells from patients with chronic GVHD.
Blood
; 123(13): 2108-15, 2014 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-24532806
13.
Comprehensive genomic characterization of five canine lymphoid tumor cell lines.
BMC Vet Res
; 12: 207, 2016 Sep 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-27639374
14.
The role of screening and monitoring for bleomycin pulmonary toxicity.
J Oncol Pharm Pract
; 22(2): 308-12, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25736276
15.
Genetic heterogeneity of diffuse large B-cell lymphoma.
Proc Natl Acad Sci U S A
; 110(4): 1398-403, 2013 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-23292937
16.
Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.
Mod Pathol
; 28(12): 1555-73, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26541272
17.
Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy.
Mod Pathol
; 28(10): 1297-314, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26248897
18.
Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions.
Mod Pathol
; 28(9): 1202-13, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26111978
19.
MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.
Blood
; 122(15): 2630-40, 2013 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23982177
20.
Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium Program.
Blood
; 121(22): 4529-40, 2013 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-23515929